Antithrombotic Therapy in Complex Percutaneous Coronary Intervention Patients Requiring Chronic Anticoagulation
The optimal antithrombotic treatment in patients receiving oral anticoagulation undergoing percutaneous coronary intervention (PCI) has been a field of intensive research. Although triple antithrombotic therapy had been, until lately, the strategy of choice, recent evidence points to the superiority...
Saved in:
Main Authors: | Despoina-Rafailia Benetou, Panayotis K Vlachakis, Charalampos Varlamos, Dimitrios Alexopoulos |
---|---|
Format: | article |
Language: | EN |
Published: |
Radcliffe Medical Media
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/e373f115d45b402495e5748cca5ec0cc |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Left Main Disease and Bifurcation Percutaneous Coronary Intervention: Focus on Antithrombotic Therapy
by: Charalampos Varlamos, et al.
Published: (2021) -
Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
by: Despoina-Rafailia Benetou, et al.
Published: (2021) -
Antithrombotic Therapy in Chronic Total Occlusion Interventions
by: Iosif Xenogiannis, et al.
Published: (2021) -
Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention
by: Dimitrios Alexopoulos, et al.
Published: (2020) -
Percutaneous Coronary Intervention for Chronic Total Occlusion
by: Giovanni Maria Vescovo, et al.
Published: (2020)